Randomized Phase II Trial of Pre-Operative Gemcitabine, Nab-Paclitaxel, and Hydroxychloroquine With or Without Avelumab (PGHA vs. PGH)
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Avelumab (Primary) ; Gemcitabine; Hydroxychloroquine; Paclitaxel
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 21 Dec 2017 Planned End Date changed from 15 Oct 2021 to 1 Jan 2021.
- 21 Dec 2017 Planned primary completion date changed from 15 Oct 2020 to 1 Jan 2021.